95086-96-7

Basic information

• Product Name: Benzamide, N-(2-methoxyethyl)-4-nitro-
• Synonyms: 4-nitro-benzoic acid-(2-methoxy-ethylamide);N-[2-(methyloxy)ethyl]-4-nitrobenzamide;4-Nitro-benzoesaeure-(2-methoxy-aethylamid);N--(2-methoxyethyl)-4-nitrobenzamide;N-(2-Methoxy-aethyl)-4-nitro-benzamid;N-(2-methoxyethyl)-p-nitrobenzamide
• CAS NO: 95086-96-7
• Molecular Formula: C10H12N2O4
• Molecular Weight: 224.216
• Mol File: 95086-96-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzamide, N-(2-methoxyethyl)-4-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, N-(2-methoxyethyl)-4-nitro-(95086-96-7)
• EPA Substance Registry System: Benzamide, N-(2-methoxyethyl)-4-nitro-(95086-96-7)

Safety Data

• Hazardous Substances Data: 95086-96-7(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 19614-29-0 1-(p-nitrobenzoyl)aziridine 
• 109-85-3 2-methoxyethylamine 
• 62-23-7 4-nitro-benzoic acid 
• 122-04-3 4-nitro-benzoyl chloride 

Downstream Products

• 1316066-55-3 4-[(6-chloro-4-pyrimidinyl)amino]-N-[2-(methyloxy)ethyl]benzamide 
• 1395885-91-2 N₄-(2-chlorophenyl)-N₂-[4-N-(2-methoxyethyl)carbamoylphenyl]pyrimidine-2,4-diamine hydrochloride 
• 95086-97-8 N-(2-methoxyethyl)-p-aminobenzamide 

Relevant articles and documents

AURORA KINASE INHIBITORS AND METHODS OF MAKING AND USING THEREOF

Described herein are inhibitors of Aurora kinase and their use in the treatment of cancer. Methods of screening for selective inhibitors of Aurora kinases are also disclosed.

COMPOUNDS AND METHODS

Disclosed are compounds having the formula (I): wherein R1, R2, R3, R4, R5, and R6 are as defined herein, and methods of making and using the same.

PYRIDINYLQUINAZ0LINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS

The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.